Company Information

Directors

  • Roger H. Kimmel 1,2,3

    Chairman of the Board
    Vice Chairman, Rothschild Inc.

  • Paul V. Campanelli

    President and Chief Executive Officer

  • Shane M. Cooke 1

    Retired President, Alkermes

  • Nancy J. Hutson, Ph.D. 3,4

    Retired Senior Vice President, Pfizer Global Research and Development

  • Michael Hyatt 2,3

    Senior Advisor, Irving Place Capital

  • Sharad S. Mansukani, M.D. 2,4

    Senior Advisor, TPG Capital LP

  • William P. Montague 1,2

    Retired Chief Executive Officer and Director, Mark IV Industries, Inc.

  • Todd B. Sisitsky 2,3

    Partner, TPG Capital LP

  • Jill D. Smith 1,4

    President and Chief Executive Officer of Allied Minds

Executive Officers*

  • Paul V. Campanelli

    President and Chief Executive Officer

  • Patrick A. Barry

    Executive Vice President and Chief Commercial Officer, U.S. Branded Business

  • Blaise Coleman

    Executive Vice President and Chief Financial Officer

  • Terrance J. Coughlin

    Executive Vice President and Chief Operating Officer

  • Matthew J. Maletta

    Executive Vice President and Chief Legal Officer

  • Antonio R. Pera

    President, Par Pharmaceutical

Senior Leadership

  • Joseph A. Barbarite

    Executive Vice President, Global Quality and Compliance

  • Mark T. Bradley

    Senior Vice President, Corporate Development and Treasurer

  • Lawrence A. Cunningham

    Executive Vice President, Human Resources

  • Rahul Garella

    Senior Vice President, Head of International Pharmaceuticals

  • Carrie A. Nichol*

    Vice President, Controller and Chief Accounting Officer

  • Brandon Rockwell

    Senior Vice President, Business Development

  • Susan Williamson

    Senior Vice President and Chief Compliance Officer

* Section 16(b) Officers

Company Secretary

  • Orla Dunlea

    International Legal Counsel and Company Secretary

Company Information

  • Auditors

    PricewaterhouseCoopers LLP
    Two Commerce Square, Suite 1700
    2001 Market Street
    Philadelphia, PA 19103-7045

  • Corporate Counsel

    A&L Goodbody
    IFSC
    North Wall Quay
    Dublin 1
    Ireland

    Skadden, Arps, Slate, Meagher & Flom LLP
    4 Times Square
    New York, NY 10036

  • Transfer Agent

    Computershare
    P.O. Box 43001
    Providence, RI 02940

    250 Royall Street
    Canton, MA 02021

  • Investor Relations

    Nina Goworek
    Senior Director, Investor Relations
    484-216-6657

  • Annual Shareholder Meeting

    Thursday, June 7, 2018 at 8:00 a.m. Irish Standard Time (IST)

    First Floor Minerva House
    Simmonscourt Road
    Ballsbridge
    Dublin 4
    Ireland

Stock Exchange

Endo common stock is listed on the NASDAQ Global Select Market under the ticker symbol ENDP. Note: NASDAQ quotes are in USD$.

SEC Form 10-K

A copy of the company’s annual report on Form 10-K, as filed with the U.S. Securities and Exchange Commission (SEC), is available on our website (www.endo.com) or may be obtained without charge by writing to:

First Floor
Minerva House
Simmonscourt Road
Ballsbridge
Dublin 4
Ireland

Caution: Forward-looking Statements

This document contains certain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and the applicable Canadian securities laws. These statements are based on management’s current expectations and are subject to changes, risks and uncertainties. Actual results may differ materially from these expectations due to changes in economic, business, competitive, market and regulatory factors, among others. More information about those factors is contained in Endo’s filings with the U.S. Securities and Exchange Commission and with securities regulators in Canada on System for Electronic Document Analysis and Retrieval.

Financial Downloads